PLSMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Pulsenmore Ltd.

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 30, 2026

$1.78−0.09 (-4.81%)

Close on Oct 19, 2026

Earnings

Quarterly results announced on Form 8-K, Item 2.02

Quarter	Reported	Time	Revenue	EPS (GAAP)	EPS (adjusted)
Q2 FY2026 Ended Jun 30, 2026	Aug 31, 2026	Before market open	–	–	–

Press releases

Announcements Pulsenmore filed with the SEC

Oct 13, 2026, 7:28 AM ET
Strengthens U.S. Commercial Leadership, Appoints Med-Tech Veteran David Woods as Chief Commercial Officer
EX-99.1 to Form 6-K
Sep 17, 2026, 7:12 AM ET
Expands Its Fertility Platform into the UK
EX-99.1 to Form 6-K
Sep 8, 2026, 7:10 AM ET
Expands into Fertility Care: Completes CE European Registration of Home Ultrasound System for Follicular Monitoring
EX-99.1 to Form 6-K
Aug 31, 2026, 7:29 AM ET
EX-99.1 to Form 6-K
EX-99.1 to Form 6-K
Aug 31, 2026, 7:29 AM ET
following discussion and analysis of our operating and financial condition and prospects provides information that we believe to
EX-99.2 to Form 6-K
Aug 31, 2026, 7:29 AM ET
Ltd. Announces Financial Results and Business Highlights for the First Half of 2026
EX-99.3 to Form 6-K
Aug 19, 2026, 7:05 AM ET
Expands Its Home Ultrasound Activity in Israel: Ichilov Adopts the Technology, Expanding Access to At-Home Pregnancy Monitoring
EX-99.1 to Form 6-K
Aug 17, 2026, 7:05 AM ET
Receives Second AI Grant Within One Month: Israel Innovation Authority Approves $1.27 Million for SmartScan AI Program
EX-99.1 to Form 6-K
Jul 13, 2026, 7:37 AM ET
Selected for Israel Innovation Authority and Ministry of Health Program to Lead a $1 Million AI Development Project
EX-99.1 to Form 6-K
Jul 1, 2026, 5:15 PM ET
OF ANNUAL GENERAL MEETING OF SHAREHOLDERS
EX-99.1 to Form 6-K
Jul 1, 2026, 5:15 PM ET
PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS
EX-99.2 to Form 6-K
Jun 25, 2026, 4:44 PM ET
Announces Pricing of $7.5 Million Private Placement with a Single Healthcare Focused Institutional Investor
EX-99.1 to Form 6-K
Jun 24, 2026, 7:08 AM ET
Announces Strategic Partnership with Ouma Health to Expand Access to Remote Prenatal Care Across the United States
EX-99.1 to Form 6-K
May 7, 2026, 4:49 PM ET
are cordially invited to attend, and notice is hereby given of, an Annual General Meeting of Shareholders of Pulsenmore Ltd. (the “ Company ”,
EX-99.1 to Form 6-K
May 7, 2026, 4:49 PM ET
PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS
EX-99.2 to Form 6-K
Mar 30, 2026, 9:05 AM ET
Announces Full Year 2025 Financial Results and Webcast
EX-99.1 to Form 6-K
Mar 18, 2026, 7:23 AM ET
EX-99.1 to Form 6-K
EX-99.1 to Form 6-K
Feb 9, 2026, 7:05 AM ET
Builds U.S. Momentum with Another Commercial Engagement Following FDA Clearance
EX-99.1 to Form 6-K
Feb 2, 2026, 7:35 AM ET
Announces First Commercial Engagement with a Leading U.S.-Based Medical Center
EX-99.1 to Form 6-K
Jan 26, 2026, 8:05 AM ET
and Clalit Health Services Launch First At-Home Follicular Monitoring Service for IVF and Fertility Preservation
EX-99.1 to Form 6-K
Jan 21, 2026, 8:21 AM ET
To Commence Trading on Nasdaq as It Expands FDA-authorized Home Prenatal Ultrasound Devices in the U.S.
EX-99.1 to Form 6-K

Where these numbers come from

Parsed from the XBRL in Pulsenmore's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is PLSM.

Revenue growth314.3% · median 12.7%

Gross margin84.2% · median 77.1%

Company	Revenue	Growth
CVRX	$61.19M	+12.0%
PLSM	40.02M ILS	+314.3%
UTMD	$36.11M	–
BWAY	$22.06M	-4.5%
PROF	$19.09M	+61.2%
BTCY	$16.40M	+13.4%

Company

Exchange: Nasdaq
Industry: Surgical & Medical Instruments & Apparatus
Fiscal year ends: December 31
Employees: 63
Auditor: Kesselman & Kesselman
SEC CIK: 2064764

Advertisement
300 × 250